Novavax, Inc. Banner Image

Novavax, Inc.

  • Ticker NVAX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Novavax, Inc. Logo Image
  • 501-1000 Employees
  • Based in Gaithersburg, Maryland
Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant vaccines for infectious diseases using its virus-like particle platform (VLP) technology. It develops vaccine product candidates that target pandemic influenza, including H1N1 and H5N1 strains; seasonal influenza; and respiratory syncytial virus (RSV).
4.8 / 5.0 (168)

Novavax, Inc. reports have an aggregate usefulness score of 4.8 based on 168 reviews.

Novavax, Inc.

Most Recent Annual Report

Novavax, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Novavax, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Novavax, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!